Introduction Clostridiodes difficile infection (CDI) is a life-threatening illness that has been
labelled as an urgent threat by the Centers for Disease prevention (CDC). Areas Covered …

Clostridioides difficile infection (CDI) affects approximately 500,000 patients annually in the
United States, of these around 30,000 will die. CDI carries significant burdens including …

Background Although comorbidities are risk factors for recurrent Clostridioides difficile
infection (rCDI), many clinical trials exclude patients with medical conditions such as …

Introduction Clostridioides difficile infection (CDI) is a recognized global threat especially for
vulnerable populations. It is of particular concern to healthcare providers as it is found in …

Background Hidradenitis suppurativa (HS) is a clinical condition characterized by the
formation of painful lumps under the skin. It often affects intertriginous areas like armpits and …

Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated
diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C …

Background During the COVID-19 pandemic, increased antibiotic prescribing and infection
prevention challenges coincided with antibiotic-resistant (AR) infection increases …

Background Clostridiodes difficile is a leading cause of healthcare-associated diarrhea. In
this study, we aimed to identify the rates and predictors for 30-day readmissions of …

Abstract Data from the National Inpatient Sample indicate that Clostridioides difficile
prevalence decreased from 10.1 (95% confidence interval [CI]= 9.9–10.3) to 8.6 (95% CI …

Background Clostridium difficile infection (CDI) is one of the rising public health threats in
the United States. It has imposed significant morbidity and mortality in the elderly population …